Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$2.6M
-32.6% from 2023
Prescriptions
11K
$231.60 per claim
Patients
1,806
2,049 prescribers
Total spending, 2024
$2.6M
$1,448.84 per patient
Medicare prescription drug plans paid $2.6M for Tranylcypromine Sulfate in 2024, for 11,298 prescriptions and refills to 1,806 patients (down 32.6% from 2023). The average cost per claim was $231.60.
New York had the highest Medicare cost for Tranylcypromine Sulfate in 2024: $300K for 1,164 claims, followed by California ($261K).
Patrick J McGrath, psychiatry in New York, NY, had the highest Medicare cost for Tranylcypromine Sulfate in 2024: 34 claims costing $16K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Patrick J McGrath New York, NY | Psychiatry | 34 | Under 11 | $16K |
| Rosalind Gold Portland, ME | Psychiatry | 13 | Under 11 | $14K |
| Fareed Tabatabai |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 2,055 | 11,119 | 1,801 | $4.3M |
| 2023 | 2,025 | 10,999 | 1,773 | $3.9M |
| 2024 | 2,049 | 11,298 | 1,806 | $2.6M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Psychiatry |
| 37 |
| Under 11 |
| $12K |
| Michael D Miller Philadelphia, PA | Psychiatry & Neurology | 21 | Under 11 | $11K |
| Timothy Lawrence Rochester, NY | Psychiatry | 15 | Under 11 | $10K |
| Lee Berman Dubuque, IA | Psychiatry | 19 | Under 11 | $10K |
| Steven Wager New York, NY | Psychiatry | 51 | Under 11 | $9,377 |
| Robert J Olson Jr. Fargo, ND | Psychiatry | 11 | Under 11 | $9,303 |
| Rajiv K Sood Hoffman Estates, IL | Internal Medicine | 25 | Under 11 | $8,936 |
| Harish Kavirajan Irvine, CA | Neuropsychiatry | 29 | Under 11 | $8,674 |
| Howard E Abrams Salem, MA | Psychiatry | 15 | Under 11 | $8,586 |
| Joseph Labricciosa Broomall, PA | Family Practice | 70 | Under 11 | $8,482 |
| Paul V Luisada Alexandria, VA | Psychiatry | 16 | Under 11 | $7,663 |
| John P O Reardon Voorhees, NJ | Psychiatry & Neurology | 42 | Under 11 | $7,662 |
| Sunil Gangwani Chesterfield, MO | Psychiatry | 16 | Under 11 | $7,577 |
| Christopher J Christian Milwaukee, WI | Psychiatry | 12 | Under 11 | $7,498 |
| Simeon S Feinberg Forest Hills, NY | Psychiatry & Neurology | 31 | Under 11 | $7,079 |
| Neil Shah North Little Rock, AR | Internal Medicine | 19 | Under 11 | $6,974 |
| Steven Zavodnick Philadelphia, PA | Psychiatry & Neurology | 15 | Under 11 | $6,962 |
| Claudia F Baldassano Philadelphia, PA | Psychiatry | 18 | Under 11 | $6,781 |
| Vincent J Fasanello Pittsford, NY | Psychiatry & Neurology | 19 | Under 11 | $6,435 |
| Bruce C Johnson Vancouver, WA | Psychiatry & Neurology | 12 | Under 11 | $6,428 |
| Ivan Delgado-Ramos Atlantic, IA | Psychiatry | 27 | Under 11 | $6,337 |
| Jack C Morgan III Memphis, TN | Psychiatry | 17 | Under 11 | $6,289 |
| Michael E Stewart Detroit Lakes, MN | Psychiatry | 20 | Under 11 | $6,219 |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novitium/Ani Ph ANIP | 4,116 | $1.0M |
| Strides Pharma STAR.NS | 4,195 | $874K |
| Actavis/Teva TEVA | 1,819 | $459K |
| Solco Healthcar | 902 | $196K |
| Par Pharm. | 172 | $31K |
| Marlex Pharm. | 94 | $9,008 |